Fraser Kearney Capital Corp.
VC Fund
Toronto, Canada
Fraser Kearney Capital Corp. is a VC fund in Toronto focused on Health Care and Medical. It is a Executive Office.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Fraser Kearney Capital Corp. invests in
Stages Fraser Kearney Capital Corp. invests in
Countries Fraser Kearney Capital Corp. invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John Francis
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 2 (100%)
- Medical 1 (50%)
- Software 1 (50%)
- Biotechnology 1 (50%)
- Medical Device 1 (50%)
Stage
- Seed 1 (50%)
- Convertible Note 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
John Francis
Managing Director
|
Managing Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oncoustics AI
|
Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M / Seed / Jul 21, 2022 | |
ManagingLife
|
ManagingLife's industry-leading digital health solution, Manage My Pain, helps patients and doctors better measure, monitor, and manage pain. Manage My Pain is a digital pain treatment companion with clinical validation and has one of the largest datasets that includes over 5M patient-reported pain outcomes from over 125,000 users from 130countries. Built into Manage My Pain is Solace, a first-of-its-kind AI companion that delivers real-time, evidence-based pain psychology support - which showed significant improvements in people who interacted with it for just 30 minutes.Manage My Pain is the leading pain app on the market, and has been licensed by hospitals and insurers across North America. Manage My Pain improves patient outcomes, reduces medical spend, and shortens disability claims. | $670K / Convertible Note / Dec 31, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Fraser Kearney Capital Corp. invest in?
Fraser Kearney Capital Corp. invests primarily in Health Care, Medical and Software startups, most often at Seed and Convertible Note stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Fraser Kearney Capital Corp.?
Public channels for Fraser Kearney Capital Corp. include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fraser Kearney Capital Corp.?
The team at Fraser Kearney Capital Corp. includes John Francis (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
